ADVANCED HR+/HER2- BREAST CANCER
Clinical trials for ADVANCED HR+/HER2- BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HR+/HER2- BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED HR+/HER2- BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets cancer growth at the genetic level
Disease control Not yet recruitingThis trial tests an experimental drug called SYH2095, taken as a daily pill, in people with advanced solid tumors that have no effective standard treatment. The drug blocks a protein (KAT6A/B) involved in cancer cell growth. The study aims to find a safe dose and check for early …
Matched conditions: ADVANCED HR+/HER2- BREAST CANCER
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New study aims to stop Chemo-Induced diarrhea in breast cancer patients
Symptom relief Not yet recruitingThis study tests whether giving atropine before treatment can prevent diarrhea in people with advanced breast cancer receiving the drug sacituzumab govitecan. About 30 participants will receive atropine alongside their cancer therapy. The goal is to improve treatment tolerance an…
Matched conditions: ADVANCED HR+/HER2- BREAST CANCER
Phase: PHASE2 • Sponsor: MedSIR • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC